Financial intelligence for Asia's healthcare markets
Remember me:

Analysis: New Zealand health tech looks to Malaysia

Leaders from New Zealand’s health technology industry are looking to Malaysia as a strategic investment opportunity to support the country’s rapidly growing healthcare market.

Malaysia’s healthcare sector is among the fastest growing industries in the country. Ambitious growth targets under the government’s Economic Transformation Program (ETP) put healthcare on course to contribute M$50.5 billion (US$12.4 billion) to Gross National Income by 2020, trebling the sector’s contribution over ten years.

Seven New Zealand health technology companies are visiting Malaysia to explore partnership opportunities and will attend this week’s Association of Private Hospitals Malaysia (APHM) International Healthcare Conference and Exhibition in Kuala Lumpur. These companies will share their expertise on how health technology can improve efficiency, enhance patient services and reduce costs.

Simon Hearsey, New Zealand’s Trade Commissioner to Malaysia, says the healthcare sector represents a huge opportunity not just for Malaysian companies but companies that have had success in other parts of the world who are willing to partner and invest to support this growth.

“Health tech has been a booming sector in New Zealand and it has helped the overall sector evolve. New Zealand companies have a long history of successful partnerships here in Malaysia, and I am excited to see how our innovative health tech companies can work with their Malaysian counterparts to develop solutions that will address the unique challenges in the healthcare sector,” he said.

Like many countries across the region, Malaysia is faced with changing patient needs caused by an ageing population and the growing prevalence of chronic disease. The healthcare sector is looking for smart technology solutions to create greater value for both the provider and patient.

A particular area of focus is how to harness big data to provide better patient care. Mark Capill, head of research and development at Orion Health, says hospitals and health authorities are capturing a significant amount of data each day but they need to manage it in a secure and safe way, and more importantly be able to use it effectively.

“Patient data can provide valuable insights that help to improve healthcare across the board. One area of focus for us is how to combine hospital data with social and environmental information about patients to create personalised health care plans. I look forward to discussing how this technology can be used to improve patient care in Malaysia,” he said.

Another company looking to use data in a more effective way is Precept Health, which provides systems to manage patient data, with a focus on critical care. These tools give healthcare professionals reliable access to comprehensive patient records, allowing them to work more efficiently and enabling them to focus on patient care.

Other New Zealand companies in attendance will showcase tools that can streamline hospital data systems, provide better diagnostic information and connect patient records to achieve greater operational efficiency for hospitals.

As technology helps to expand healthcare outside of the traditional hospital setting, Trade Commissioner Simon Hearsey is confident that collaboration will be key to the continued innovation. “New Zealand businesses are born with a global outlook. Through increased collaboration with our partners in Malaysia, we can develop solutions that will have an impact across the healthcare landscape: from hospitals and community clinics to telemedicine and home care,” said Hearsey.

Posted on: 30/07/2018 UTC+08:00


News

Beijing-based healthcare service platform Miaoshou Doctor has completed a ¥1.5 billion (US$232 million) Series F round of financing.
Chinese digital technology company, Xisoft Technology, which focuses on hospital operation management, has raised ¥100 million ($15.65 million) in Series A+ financing.
Hearing health company Olive Union has closed a $7M Series B round led by Beyond Next Ventures, Bonds Investment Groups and Japan Policy Finance Corporation.
Long Hill Capital, a venture capital firm in China, has closed on more than $300 million for its third fund on 15 March.
Eluminex Biosciences, an ophthalmic biotechnology company has completed a $50 million Series A financing co-led by Lilly Asia Ventures, GL Ventures (venture capital arm of Hillhouse Capital), and Quan Capital.
TVM Capital Healthcare, a global private equity and growth capital firm focused on emerging markets, has announced two team additions today.
In partnership with VeChain and DNV GL, Renji Hospital, a hospital in China affiliated with the Shanghai Jiaotong University School of Medicine, has launched the world's first blockchain-enabled intelligent tumour treatment centre.
Hong Kong-based BuyHive, a new global sourcing start-up that connects buyers with trusted verified overseas suppliers, has launched a PPE programme to help US companies optimise their post-Covid supply chains.



Analysis

L.E.K. Consulting’s Fabio La Mola tells HealthInvestor Asia about a healthcare market going through major changes – creating significant opportunities for investors in the region.
Edwin Tong, senior minister for health, explains how the Ministry of Health in Singapore is supporting the growth in the number of seniors with Alzheimer's.
Penny Wan, regional vice-president and general manager, Japan and APAC, Amgen, writes about the public health challenge of cardiovascular diseases.
French-based international ophthalmic optics company Essilor has signed Letters of Intent with the Royal Government of Bhutan and the Central Monastic Body to strengthen the country’s vision care infrastructure.
April Chang, country manager at Cigna Singapore, argues that wellness programmes at work can lead to reduced absenteeism, higher productivity and increased morale among employees.
Steven Fang understands how to set up a healthcare company. Not only is he chief executive and founder of ASX-listed oncology company Invitrocue, he was also the founder of Singapore-based Cordlife Group, a healthcare company which provides cord blood and cord lining banking services.
Imagine a world in which you can consult with your doctor via video. She asks for a blood sample, which can be collected and analysed from a device in your home. After that is diagnosed, the prescription is automatically sent to the pharmacy and Uber then picks it up. The time from diagnosis to drugs at your home is only 60 minutes.
The digitisation of health data through blockchain technology is a groundbreaking solution that will empower patients and provide them with better access to healthcare.


Podcasts

HealthInvestor Asia twitter feed










A Rolex Yacht-Master I Ladies Replica watch is basically a person watch that's crafted inside an identical fashion with a well-known maker¡¯s real piece. Purchasing Replica Watches seems as an excellent idea. Anyway,ON perfectcloneshop.com replica Rolex Yacht-Master Ladies watches are affordable, look almost the identical while using real ones and could easily acquired.